Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-25-001763
Filing Date
2025-03-27
Accepted
2025-03-27 08:15:31
Documents
2
Period of Report
2025-03-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_032725.htm 6-K 6905
2 PRESS RELEASE exh_991.htm EX-99.1 5121
  Complete submission text file 0001171843-25-001763.txt   13053
Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970 4552656554
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 25775424
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)